Following primary infection of healthy individuals, human cytomegalovirus (HCMV) is met with a robust immune response, resulting in an asymptomatic infection and subsequent establishment of latency (Crough & Khanna, 2009) . To date, HCMV remains one of the leading viral agents of disease in immunosuppressed transplant patients and is a cause of severe morbidity in late-stage AIDS sufferers and cancer patients (Khoshnevis & Tyring, 2002; Whitman et al., 2005) . The threat from HCMV is exacerbated by the dual threat of primary infection/ reinfection and virus reactivation within the host. As many instances of viral disease result from HCMV reactivation, many studies have analysed the regulation of latency and reactivation by using experimental models (Bego & St Jeor, 2006; Goodrum et al., 2007; Hahn et al., 1998; Hummel & Abecassis, 2002; Minton et al., 1994; Reeves et al., 2005a) and the analysis of naturally latent tissue from healthy donors (Kondo et al., 1996; Reeves et al., 2005b; Slobedman & Mocarski, 1999; Soderberg-Naucler et al., 1997; Taylor-Wiedeman et al., 1994 ).
An informed consensus supports the myeloid lineage as an important site of HCMV latency and carriage (Hahn et al., 1998; Mendelson et al., 1996; Sindre et al., 1996; TaylorWiedeman et al., 1991) and that terminal myeloid differentiation is concomitant with HCMV reactivation (Hahn et al., 1998; Prosch et al., 1999; Reeves et al., 2005a, b; Soderberg-Naucler et al., 1997; Taylor-Wiedeman et al., 1994) . A recurrent theme in HCMV latency/reactivation, this differentiation-dependent permissiveness also applies to lytic infection (Hertel et al., 2003; Lathey & Spector, 1991; Riegler et al., 2000) .
Latently infected cells are, by definition, unable to support the viral lytic transcription programme -pivotal to this is failure of immediate-early (IE) gene expression. However, increasing evidence suggests the presence of a limited but distinct viral transcription profile in latently infected cells (Cheung et al., 2006; Goodrum et al., 2002; Kondo et al., 1996) , although most are not latency-specific: the cytomegalovirus latency transcripts (CLTs) (Kondo et al., 1996; Lunetta & Wiedeman, 2000; White et al., 2000) LUNA (latent undefined nuclear antigen; UL81-82as) (Bego et al., 2005) and UL138 (Petrucelli et al., 2009 ) are all detected during lytic infection, and the viral homologue of interleukin-10 (IL-10) expressed during HCMV latent infection (LAcmv-IL10) is an alternately spliced form of the lytic viral IL-10 (cmvIL-10) encoded from the UL111A locus (Jenkins et al., 2004; Kotenko et al., 2000) .
Major IE gene expression during latency and reactivation correlates with the post-translational modifications of histones associated with the major immediate-early promoter (MIEP). In both natural and experimental latency in CD34
+ progenitor cells or CD14 + monocytes, the MIEP is associated with the repressive chromatin marker heterochromatin protein 1 (HP-1) (Murphy et al., 2002; Reeves et al., 2005a, b) . This association is dynamic, as in cells reactivating HCMV [i.e. CD34 + -derived dendritic cells (DCs)], HP-1 is no longer bound and instead the MIEP is associated with acetylated histones, suggesting that myeloid differentiation and post-translational modification of histones associated with the MIEP occur concomitantly (Reeves et al., 2005b) . Interestingly, this dynamic association between histone modifications and viral gene promoters is evident in the regulation of all phases of lytic gene expression (Cuevas-Bennett & Shenk, 2008; Groves et al., 2009; Nitzsche et al., 2008; Reeves et al., 2006) . Consequently, we asked whether expression of viral latent gene expression was subject to the same histonemediated mechanisms of transcriptional regulation.
Our analyses focused on the recently identified LUNA gene product -a novel RNA species identified by RACE (rapid amplification of cDNA ends) analysis of latent transcripts arising from the UL81-82 region in seropositive donors' monocytes (Bego et al., 2005) . Using previously described RT-PCR conditions shown to amplify LUNA (UL81R2/ UL82F1 and nested primers UL81R3/UL82F2; Bego et al., 2005) and IE (Reeves et al., 2005b) RNA specifically, we confirmed the expression of LUNA in two of three seropositive donors' monocytes ( To analyse the kinetics of LUNA gene expression in latently infected CD34
+ progenitor cells in more detail, we used a previously described HCMV latency model (Reeves et al., 2005a) . Experimentally infected CD34
+ cells were differentiated into immature DCs (Strobl et al., 1997) and then matured with lipopolysaccharide (LPS) (500 ng ml 21 ; Sigma-Aldrich). Following infection, LUNA RNA expression was detectable after 2 days (Fig. 2a, b) , contrasting with lytic infection, where LUNA expression was detectable within 4 h (Bego et al., 2005) . Culture to an immature DC phenotype resulted in a decrease in the level of LUNA gene expression (Fig. 2a, lane 4 ; Fig. 2b , lane 6). However, DC maturation promoted a second phase of LUNA expression (Fig. 2a, lane 5; Fig. 2b , lanes 7 and 8), presumably as reactivation of the lytic cycle occurred. We also tested the samples for UL138 expression, using previously described RT conditions to detect the viral transcript during natural latency (Goodrum et al., 2007) . In contrast to LUNA, UL138 expression was detectable within 1 day postinfection of CD34 + cells (Fig. 2b , lane 2), and accumulated up to day 3 (Fig. 2b, lane 4) . However, similar to LUNA, we did observe a general decrease in UL138 expression as differentiation progressed beyond day 3 (Fig. 2a, lane 3 ; Fig. 2b , lanes 4-7) and then a subsequent re-expression of UL138 following DC maturation (Fig. 2b, lanes 8-11) . These changes did not appear to be due to any overt decreases in viral genome copy number during differentiation ( Fig. 2c) , as reported by Petrucelli et al. (2009) . A caveat of this analysis was the detection of weak but detectable UL138 RNA expression just prior to LPS maturation (Fig. 2a, lane 4 ; Fig. 2b, lane 7) . However, the function of UL138 during HCMV latency remains unresolved and thus the significance of this observation is unclear -albeit intriguing.
Finally, we asked whether expression of the viral tegument protein pp71, a potent transactivator of the MIEP during lytic infection (Liu & Stinski, 1992; Spaete & Mocarski, 1985) , could promote reactivation of major IE gene expression analogous to that proposed for VP16 during herpes simplex virus type 1 reactivation (Thompson & Sawtell, 2006; Thompson et al., 2009) . However, no pp71 expression was detected in latently infected cells immediately prior to maturation and reactivation (Fig. 2b, lanes 1-9) , even though pp71 expression was readily detectable at 4 days post-maturation (Fig. 2b, lane 12) -concomitant with the known reactivation of lytic gene expression in this experimental model of HCMV latency (Reeves et al., 2005a) . Detectable UL82 RNA expression did not precede reactivation of HCMV major IE gene expression and thus, at least in this experimental model of HCMV latency, there is no evidence for pp71 acting as a 'latency breaker', as proposed for VP16 (Thompson et al., 2009 ).
In previous analyses of experimental and natural latency, we have correlated the regulation of viral IE gene expression with specific post-translational modifications of histones associated with the MIEP (Reeves et al., 2005a, b) . Consequently, we asked whether LUNA promoter activity correlated with specific post-translational modifications of histone proteins during HCMV latency. Chromatin immunoprecipitation (ChIP) assays were performed on experimentally latent CD34 + cells (no differentiation) at 10 days post-infection (Fig. 3a, b) and analysed by using primers targeting the MIEP (Murphy et al., 2002; Reeves et al., 2005a) and UL81-82as promoter (59-GCGGGTTCCAATCAGCAGCAGC-39 and 59-CAGC-TACCTTGGCACCTCCGG-39; T m , 55 u C; 1.5 mM MgCl 2 ). The UL81-82as promoter was associated predominantly with acetylated histone H4 (Fig. 3a, lane 3) , which would be consistent with LUNA transcription in latently infected cells. In direct contrast was the association of the MIEP with markers of transcriptional repression (Fig. 3b, lane 4) - probably due to the continued action of transcriptional repressors YY1 and ERF and the chromatin-remodelling enzymes with which they interact (Bain et al., 2003; Liu et al., 1994; Murphy et al., 2002; Wright et al., 2005) .
Finally, we analysed the chromatin bound to the LUNA promoter in naturally latent cells previously characterized for histone occupancy at the MIEP (Reeves et al., 2005b) . Southern blot analysis of naturally latent CD34 + cells isolated from a healthy seropositive donor showed that the LUNA promoter was again associated predominantly with acetylated histones (Fig. 3b, lane 3 ; blot was probed with a 32 P-radiolabelled DNA probe generated using internal primers 59-GAGCTGAAACGCGATCTGTTTGC-39 and 59-CCGGTGGGAGTACACCGGTAG-39). These data correlate with the state of histones associated with the LUNA promoter during experimental latency (Fig. 3a) . Thus, in naturally latent individuals, the LUNA promoter is in a potentially active form correlating with the detection of LUNA gene expression in latent cells.
In this study, we have begun to characterize the regulation of latent HCMV gene expression. Using experimental and natural latency models, we have shown that we can detect LUNA (and UL138) gene expression in latently infected cells that do not support IE gene expression (Reeves et al., 2005a, b) -consistent with the prediction that LUNA and UL138 are latency-associated transcripts (Bego et al., 2005; Goodrum et al., 2002 Goodrum et al., , 2007 . Interestingly, we observed that latent viral gene expression was not constant in this model whereby, as the cells differentiated, the levels of latent gene expression fluctuated. These data suggest that transition from latency to reactivation upon myeloid-cell differentiation may be a continuously evolving event, rather than a single point of transition. A similar hypothesis has been postulated for the pattern of MIE CLT expression during latency, whereby expression is mainly restricted to a specific population of granulocyte/macrophage progenitor cells within the myeloid lineage rather than throughout latency (Mocarski et al., 2006) . A critical step of HCMV reactivation is robust induction of MIEP activity. However, it is also likely that subsequent steps in the virus life cycle will themselves require specific changes in the cellular environment to permit full reactivation of infectious virions -changes probably associated with CD34
+ cell differentiation to mature DCs. This view is supported by the relatively low efficiency of reactivation of infectious virus from naturally latent carriers observed ex vivo after differentiation of CD34 + progenitors to DCs (Reeves et al., 2005b) , the abortive reactivation detected in monocyte-derived macrophages (Taylor-Wiedeman et al., 1994) and also an in vitro study in the THP1 cell line, showing that ectopic IE72 and IE86 gene expression reactivated early gene expression, but not infectious virus (Yee et al., 2007) . Understanding what these differentiation-dependent cellular changes are and their impact on the provision of molecular cues needed to reactivate full productive infection will be essential to understand virus reactivation fully in terminally differentiated myeloid cells.
It is, however, likely that the changes in latent viral gene expression that we observed during myeloid differentiation relate to changes in the expression of cellular transcription factors that regulate the activity of latent gene promoters. The model for repression of the MIEP during latency involves the recruitment of histone deacetylases and methylases by transcriptional repressors such as YY1 and ERF (Liu et al., 1994; Wright et al., 2005) . We hypothesize that a similar mechanism, with the opposite effect, promotes the observed acetylation of histones bound to the LUNA promoter and thus activates gene expression in undifferentiated myeloid cells. Binding sites in the LUNA promoter for both GATA-1 and GATA-2 -which play critical roles in the regulation of cellular gene expression in haematopoietic progenitor cells (Ferreira et al., 2005; Weiss & Orkin, 1995) -are present. GATAs interact with histone acetylases p300/CBP (Boyes et al., 1998; Hung et al., 1999) and the Friends of GATA family of proteins (Fox et al., 1999; Tevosian et al., 1999) and, by transfection in myeloid progenitor cells, we have observed activation of the LUNA promoter by GATA-2 (unpublished observations). Hypothetically, transcriptional activation of the LUNA promoter in latently infected cells could be mediated via GATA-induced modifications of its chromatin structure. Indeed, GATA-2 expression is elevated in myeloid progenitor cells and decreases upon cellular differentiation On: Sat, 27 Jul 2019 01:16:48 (Ferreira et al., 2005; Tsai & Orkin, 1997) . In conclusion, our data suggest that cellular changes associated with differentiation of haematopoietic progenitor cells to DCs are likely to play a pivotal role not only in the repression and reactivation of IE gene expression, but also in the regulation of latent viral gene expression. Indeed, it is often tempting to consider latency and reactivation as distinct phases of the virus life cycle, occurring in two phenotypically distinct cell types. However, these data suggest that a dynamic regulation of both latent and lytic gene expression and the transition between these two phases result from continuous responses to cellular changes occurring throughout the course of myeloid differentiation. As we characterize these changes, we will further our understanding of the critical steps that promote the transition from HCMV latency to the reactivation of infectious virus which, in vivo, can result in such devastating consequences.
